© Vivici
The Netherlands-based alt-dairy start-up, Vivici, has announced it has achieved self-affirmed Generally Recognized as Safe (GRAS) status for its beta-lactoglobulin protein in the US.
Vivici’s beta-lactoglobulin is a highly pure dairy whey protein equivalent to nature’s version, created through precision fermentation. The protein is said to contain all essential amino acids required by the human body, have a high amount of leucine and branched-chain amino acids (BCAA) and be rapidly absorbed in the blood plasma.
The ingredient is also free from lactose, cholesterol, hormones and antibiotics. The protein has a neutral colour and flavour and, according to Vivici, is ready for use across a wide range of products, including ready-to-mix protein powders, protein bars and RTD protein beverages.
Vivici’s CTO, Marcel Wubbolts, said: “Nutritionally, Vivici’s beta-lactoglobulin isolate is superior to plant protein isolates, even outperforming whey protein isolates in specific applications because it’s higher in the amino acids beneficial for muscle growth and recovery”.
Vivici’s CEO Stephan van Sint Fiet added: “We want to work closely with all innovative food and beverage players in the market who believe their brand could benefit from a more sustainably produced ethically sourced, yet highly functional protein ingredient. The focus of our food science team is to support our brand customers to bring outstanding products to market.”
© FoodBev Media Ltd 2024
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry. Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial
Your privacy We use small files known as ‘cookies’ to enhance your experience of the FoodBev website and analyse site-traffic. Read about how we use cookies or how you may control them in our updated privacy policy and cookie policy. If you continue to use this site, you consent to our use of cookies. Click the ‘OKAY‘ button at the top right of this panel to accept or click here for more information.